ARTES offers a range of biosimilar producing cell lines and processes for out-licensing and technology transfer. The listed cell lines are based on yeast, E. coli or mammalian expression system.

Inter­feron alpha2ayeast; mar­keted in Mena region; new tech­nol­ogy with improved yield; RCB, USP, DSP IPC/QC protocols available; PEGy­lated process available
Inter­feron alpha2byeast; licensed to India; RCB, USP, DSP IPC/QC protocols available; PEGy­lated process available
Hirudinyeast; mar­keted in Mena region; new tech­nol­ogy with improved yield avail­able, MCB/WCB, USP, DSP, IPC/QC protocols available
Bivalirudinyeast; licensed to Egypt; RCB, USP, DSP IPC/QC protocols available
Full length factor VIIImammalian; MCB/WCB, USP, DSP IPC/QC protocols available
Insulinyeast; cell line and process as mar­keted in India; RCB, USP, DSP IPC/QC protocols available
Detemiryeast; RCB, USP protocols available; IPC/QC & DSP devel­op­ment time: approx. 6 months
Liraglutideyeast; RCB, USP protocols available; IPC/QC & DSP devel­op­ment time: approx. 6 months
Lisproyeast; proof-of-concept for expres­sion achieved; cell line & process to be devel­oped; devel­op­ment time: approx. 9 months
Glarginyeast; proof-of-concept for expres­sion achieved; cell line & process to be devel­oped; devel­op­ment time: approx. 9 months
Teduglutideyeast; cell line & process to be devel­oped; devel­op­ment time: approx. 9 months
Aspartyeast; cell line & process to be devel­oped; devel­op­ment time: approx. 9 months
G-CSFE. coli; RCB, USP protocols available; IPC/QC & DSP development time: approx. 6 months
hGrowth Hor­moneyeast; RCB, USP protocols available, IPC/QC & DSP devel­op­ment time: approx. 6 months
PTHyeast; MCB/WCB, USP; DSP IPC/QC protocols available
Follicle stimulating Hormonemammalian; MCB/WCB, USP, DSP IPC/QC protocols available
Staphy­lok­i­naseyeast; RCB, USP, DSP IPC/QC protocols avail­able
HSAyeast; RCB, USP protocols available; IPC/QC & DSP development time: approx. 6 months

To obtain a quote, please con­tact us at info(at)artes-biotechnology.com indi­cat­ing name of the biosimilar process of interest to you. We will revert to you with a ded­i­cated offer spec­i­fy­ing deliv­ery times and costs.